A group of seven Qiming-affiliated entities filed Amendment No. 2 to Schedule 13G with the SEC on November 3, 2026, disclosing their beneficial ownership positions in Connect Biopharma Holdings Ltd, a clinical-stage biopharmaceutical company headquartered in San Diego, California, as of a September 30, …
Juliano de Carvalho Dantas, Executive Vice President of Innovation, R&D, Digital and IT at AXIA Energia S.A. (OTC:AXIAY), filed a Form 4 on November 3, 2026 disclosing a stock option exercise transaction dated October 30, 2026.
William Edward Harrell Jr., Co-President of Urban One, Inc.'s Audio Division, filed a Form 4 on November 3, 2026, disclosing changes in his beneficial ownership of Urban One Class D shares (UONEK) stemming from transactions on October 30, 2026.
Anand Kiran Parikh, President and CEO of Faeth Therapeutics, Inc. (NASDAQ:FTH), filed a Form 4 on November 3, 2026, disclosing a gift of 100,000 shares of common stock to the AKP Irrevocable Trust on October 30, 2026.
Director Antony Prabhu filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 22,106 shares of reAlpha Tech Corp. common stock on October 30, 2026, as quarterly compensation for board service.
Director Dimitrios Angelis filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 22,106 shares of reAlpha Tech Corp. common stock on October 30, 2026, as quarterly director compensation.
Director Swaminathan Balaji filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 22,106 shares of reAlpha Tech Corp. common stock as quarterly director compensation for the quarter ended September 30, 2026.
Ligand Pharmaceuticals Incorporated filed Amendment No. 2 to its Schedule 13D with the SEC on November 3, 2026, disclosing a planned $33,750,000 investment in Pelthos Therapeutics Inc. and the issuer's entry into a merger agreement with Castle Creek Biosciences, Inc., with the triggering event …
Director Joshua G. Welch filed a Form 4 with the SEC on November 3, 2026, disclosing a series of in-kind liquidation distributions of America's Car-Mart, Inc. common stock from Vicuna Capital I, LP dated October 31, 2026.
Adam C. Spice, Chief Financial Officer of Rocket Lab Corp (NASDAQ:RKLB), filed a Form 4 on November 3, 2026, disclosing the exercise of a stock option and the sale of 140,157 shares of common stock on November 2, 2026, pursuant to a pre-established Rule …